<code id='A9991F11DF'></code><style id='A9991F11DF'></style>
    • <acronym id='A9991F11DF'></acronym>
      <center id='A9991F11DF'><center id='A9991F11DF'><tfoot id='A9991F11DF'></tfoot></center><abbr id='A9991F11DF'><dir id='A9991F11DF'><tfoot id='A9991F11DF'></tfoot><noframes id='A9991F11DF'>

    • <optgroup id='A9991F11DF'><strike id='A9991F11DF'><sup id='A9991F11DF'></sup></strike><code id='A9991F11DF'></code></optgroup>
        1. <b id='A9991F11DF'><label id='A9991F11DF'><select id='A9991F11DF'><dt id='A9991F11DF'><span id='A9991F11DF'></span></dt></select></label></b><u id='A9991F11DF'></u>
          <i id='A9991F11DF'><strike id='A9991F11DF'><tt id='A9991F11DF'><pre id='A9991F11DF'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          knowledge

          author:entertainment    - browse:98177
          Senate health committee Chair Bernie Sanders
          Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

          Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

          advertisement

          But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time